Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 385-393

  Ohri, Nitin ^a   Dicker, Adam P ^a   Lawrence, Yaacov Richard ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Generalized linear quadratic; Hypofractionated; Linear quadratic; Radiosensitization; Radiosurgery

Indexed keywords

AVERAGE ERRORS; CANCER CELL LINES; CELL SURVIVAL; CLINICAL STUDY; CLONOGENIC SURVIVAL ASSAYS; COMBINED MODALITY TREATMENT; CONCURRENT CHEMOTHERAPY; DATA POINTS; EQUIVALENT DOSE; HIGH DOSE; HYPOFRACTIONATED; IN-VITRO; IN-VITRO ASSAYS; LINEAR QUADRATIC; LINEAR-QUADRATIC MODELS; METHOD OF MODELING; MULTITARGET; POTENTIAL BENEFITS; RADIO-SENSITIZATION; RADIOSURGERY; SURVIVING FRACTIONS;

ASSAYS; CELL CULTURE; MATHEMATICAL MODELS; RADIOTHERAPY;

CHEMOTHERAPY;

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ERLOTINIB; GEMCITABINE; NAVELBINE; OXALIPLATIN; PACLITAXEL; RADIOSENSITIZING AGENT; TEMOZOLOMIDE;

ANALYTICAL ERROR; ARTICLE; CALCULATION; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL ASSAY; CELL KILLING; CELL SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOFRACTIONATED RADIOTHERAPY; IN VITRO STUDY; MATHEMATICAL MODEL; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; DOSE FRACTIONATION; GLIOBLASTOMA; HEAD AND NECK NEOPLASMS; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; NEOPLASMS; PANCREATIC NEOPLASMS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 84859871519     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.1990     Document Type: Article

References (58)

1. D.W. Andrews, C.B. Scott, and P.W. Sperduto Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial Lancet 363 2004 1665 1672
2. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
3. C.R. King, J.D. Brooks, and H. Gill Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer Int J Radiat Oncol Biol Phys 2011
4. P.C. Gerszten, S.A. Burton, and C. Ozhasoglu Radiosurgery for spinal metastases: Clinical experience in 500 cases from a single institution Spine (Phila Pa 1976) 32 2007 193 199
5. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694
6. E.J. Hall, and A.J. Giaccia Radiobiology for the radiologist 2006 Lippincott Williams & Wilkins Philadelphia, PA
7. J.P. Kirkpatrick, J.J. Meyer, and L.B. Marks The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery Semin Radiat Oncol 18 2008 240 243
8. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
9. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
10. W. Curran, C. Scott, and C. Langer Longterm benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410 Am Soc Clin Oncol Vol 22 2003 621
11. J.P. Pignon, A. le Maitre, and E. Maillard Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
12. J.A. Green, J.M. Kirwan, and J.F. Tierney Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis Lancet 358 2001 781 786
13. J.P. Gerard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
14. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
15. J.Z. Wang, Z. Huang, and S.S. Lo A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy Sci Transl Med 2 2010 39 48
16. E. van Rongen, E.L. Travis, and H.D. Thames Jr. Repair rate in mouse lung after clinically relevant radiation doses per fraction Radiat Res 141 1995 74 78
17. E. van Rongen, H.D. Thames Jr., and E.L. Travis Recovery from radiation damage in mouse lung: Interpretation in terms of two rates of repair Radiat Res 133 1993 225 233
18. J.F. Fowler, C.A. Whitsed, and M.C. Joiner Repair kinetics in mouse lung: A fast component at 1.1 Gy per fraction Int J Radiat Biol 56 1989 335 353
19. V. Vegesna, H.R. Withers, and J.M. Taylor Repair kinetics of mouse lung Radiother Oncol 15 1989 115 123
20. C.S. Parkins, C.A. Whitsed, and J.F. Fowler Repair kinetics in mouse lung after multiple X-ray fractions per day Int J Radiat Biol 54 1988 429 443
21. E.L. Travis, H.D. Thames, and T.L. Watkins The kinetics of repair in mouse lung after fractionated irradiation Int J Radiat Biol Relat Stud Phys Chem Med 52 1987 903 919
22. T.T. Puck, and P.I. Marcus Action of x-rays on mammalian cells J Exp Med 103 1956 653 666
23. M. Astrahan Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation Med Phys 35 2008 4161 4172
24. J.F. Fowler Differences in survival curve shapes for formal multi-target and multi-hit models Phys. Med. Biol 9 1964 177
25. S.B. Curtis Lethal and potentially lethal lesions induced by radiation- A unified repair model Radiat Res 106 1986 252 270
26. M. Guerrero, and X.A. Li Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy Phys Med Biol 49 2004 4825 4835
27. T.S. Kehwar, R.P. Rathore, and S.J. Supe Many component model and its parameters to fractionated irradiation Strahlenther Onkol 171 1995 573 580
28. C. Park, L. Papiez, and S. Zhang Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
29. J.F. Fowler How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int j radiat oncol biol phys 2007;68:1491-1495) Int J Radiat Oncol Biol Phys 71 2008 326 329 [Erratum.]
30. M. Kasibhatla, J.P. Kirkpatrick, and D.M. Brizel How much radiation is the chemotherapy worth in advanced head and neck cancer? Int J Radiat Oncol Biol Phys 68 2007 1491 1495
31. B. Jones, and R.G. Dale The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy Br J Radiol 78 2005 939 944
32. A.K. Speke, and R.P. Hill Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time Tpot. Int J Radiat Oncol Biol Phys 31 1995 847 856
33. M. Garcia-Barros, F. Paris, and C. Cordon-Cardo Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 2003 1155 1159
34. Z. Fuks, and R. Kolesnick Engaging the vascular component of the tumor response Cancer Cell 8 2005 89 91
35. J.M. Brown, and A.C. Koong High-dose single-fraction radiotherapy: Exploiting a new biology? Int J Radiat Oncol Biol Phys 71 2008 324 325
36. D.J. Carlson, P.J. Keall, and B.W. Loo Jr. Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia Int J Radiat Oncol Biol Phys 79 2011 1188 1195
37. J.M. Brown, M. Diehn, and B.W. Loo Jr. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer Int J Radiat Oncol Biol Phys 78 2010 323 327
38. A. Chakravarti, M.G. Erkkinen, and U. Nestler Temozolomide-mediated radiation enhancement in glioblastoma: A report on underlying mechanisms Clin Cancer Res 12 2006 4738 4746
39. W.J. Kil, D. Cerna, and W.E. Burgan In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide Clin Cancer Res 14 2008 931 938
40. K.A. van Nifterik, J. van den Berg, and L.J. Stalpers Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines Int J Radiat Oncol Biol Phys 69 2007 1246 1253
41. J. van Rijn, J.J. Heimans, and J. van den Berg Survival of human glioma cells treated with various combination of temozolomide and X-rays Int J Radiat Oncol Biol Phys 47 2000 779 784
42. K. Pekkola-Heino, J. Kulmala, and R. Grenman Carboplatin-radiation interaction in squamous cell carcinoma cell lines Arch Otolaryngol Head Neck Surg 118 1992 1312 1315
43. N. Zhang, K. Erjala, and J. Kulmala Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro Radiother Oncol 92 2009 388 392
44. G.P. Amorino, V.M. Hamilton, and H. Choy Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro Radiat Oncol Invest 7 1999 343 352
45. J.W. Bergs, N.A. Franken, and R. ten Cate Effects of cisplatin and gamma-irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells Mutat Res 594 2006 148 154
46. C. van Bree, N. Castro Kreder, and W.J. Loves Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines Int J Radiat Oncol Biol Phys 54 2002 237 244
47. M. Zhang, M. Boyer, and L. Rivory Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells Int J Radiat Oncol Biol Phys 58 2004 353 360
48. T.S. Lawrence, A.W. Blackstock, and C. McGinn The mechanism of action of radiosensitization of conventional chemotherapeutic agents Semin Radiat Oncol 13 2003 13 21
49. M.A. Morgan, A. Meirovitz, and M.A. Davis Radiotherapy combined with gemcitabine and oxaliplatin in pancreatic cancer cells Transl Oncol 1 2008 36 43
50. Z. Symon, M. Davis, and C.J. McGinn Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: From the laboratory to the clinic Int J Radiat Oncol Biol Phys 53 2002 140 145
51. P.H. Gutin, F.M. Iwamoto, and K. Beal Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas Int J Radiat Oncol Biol Phys 75 2009 156 163
52. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
53. K.W. Roh, J.S. Jang, and M.S. Kim Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer Int J Radiat Oncol Biol Phys 74 2009 1348 1355
54. Cengiz M., Ozyigit G., and Yazici G. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors Int J Radiat Oncol Biol Phys 81 2011 104 109
55. A. Takeda, N. Sanuki, and E. Kunieda Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm Int J Radiat Oncol Biol Phys 73 2009 442 448
56. Y. Nagata, M. Hiraoka, and T. Mizowaki Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group Int J Radiat Oncol Biol Phys 75 2009 343 347
57. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs. gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026
58. A. Mahadevan, S. Jain, and M. Goldstein Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 78 2010 735 742